title: Lymphoid-tissue stromal cells coordinate innate defense to cytomegalovirus.
abstract: During mouse cytomegalovirus (MCMV) infection, the first wave of type I interferon (IFN-I) production peaks at ≈ 8 h. This IFN-I emanates from splenic stromal cells located in the marginal zone (MZ) and requires B cells that express lymphotoxin. The amount of IFN-I produced at these initial times is at least equivalent in magnitude to that produced later by dendritic cells (≈ 36 to 48 h), but the relative roles of these two IFN-I sources in regulating MCMV defense remain unclear. Here we show that IFN-I produced by MZ stromal cells dramatically restricts the first measurable burst of viral production, which occurs at ≈ 32 h. This primary innate control by IFN-I is partially mediated through the activation of natural killer (NK) cells, which produce gamma interferon in an IFN-I-dependent fashion, and is independent of Ly49H. Strikingly, MCMV production in the spleens of immunocompetent mice never increases at times after 32 h. These results highlight the critical importance of lymphoid-tissue stromal cells in orchestrating the earliest phase of innate defense to MCMV infection, capping replication levels, and blocking spread until infection is ultimately controlled.
authors.affiliation: Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA.
authors.forename: Shilpi
authors.initials: S
authors.lastname: Verma
authors.forename: Qiao
authors.initials: Q
authors.lastname: Wang
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Chodaczek
authors.forename: Chris A
authors.initials: CA
authors.lastname: Benedict
mesh_terms: D000818:Animals; D003587:Cytomegalovirus / Q000276:immunology* / Q000502:physiology; D003586:Cytomegalovirus Infections / Q000276:immunology* / Q000821:virology; D003713:Dendritic Cells / Q000276:immunology / Q000821:virology; D005260:Female; D006801:Humans; D007113:Immunity, Innate; D007370:Interferon Type I / Q000276:immunology; D008221:Lymphoid Tissue / Q000276:immunology* / Q000821:virology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D013154:Spleen / Q000276:immunology / Q000821:virology; D017154:Stromal Cells / Q000276:immunology* / Q000821:virology
chemical_list: D007370:Interferon Type I
references.citation: J Immunol. 1996 Jun 15;156(12):4746-56
references.pmid: 8648121
references.citation: PLoS Biol. 2011 Mar;9(3):e1000598
references.pmid: 21408089
references.citation: J Virol Methods. 2000 Sep;89(1-2):61-73
references.pmid: 10996640
references.citation: J Exp Med. 1998 Aug 3;188(3):577-88
references.pmid: 9687534
references.citation: F1000Res. 2012 Aug 02;1:8
references.pmid: 24358807
references.citation: Immunol Rev. 2011 Sep;243(1):109-18
references.pmid: 21884171
references.citation: J Gen Virol. 2009 Jan;90(Pt 1):33-43
references.pmid: 19088270
references.citation: Cell Host Microbe. 2012 Oct 18;12(4):571-84
references.pmid: 23084923
references.citation: J Immunol. 2005 Jun 1;174(11):7217-25
references.pmid: 15905567
references.citation: J Interferon Cytokine Res. 2006 Nov;26(11):804-19
references.pmid: 17115899
references.citation: Nat Immunol. 2011 Nov 20;13(1):51-7
references.pmid: 22101728
references.citation: Annu Rev Immunol. 2005;23:787-819
references.pmid: 15771586
references.citation: J Immunol. 2008 May 1;180(9):5799-803
references.pmid: 18424698
references.citation: EMBO J. 1998 Feb 16;17(4):1087-95
references.pmid: 9463386
references.citation: J Biol Chem. 2005 May 13;280(19):18651-7
references.pmid: 15767254
references.citation: Immunity. 2004 Jul;21(1):107-19
references.pmid: 15345224
references.citation: Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8826-31
references.pmid: 12060703
references.citation: J Exp Med. 1994 Jan 1;179(1):185-93
references.pmid: 8270864
references.citation: J Clin Virol. 2002 Aug;25 Suppl 2:S23-36
references.pmid: 12361754
references.citation: Int Immunol. 2008 Jan;20(1):45-56
references.pmid: 18000008
references.citation: Virology. 1997 Jan 6;227(1):168-79
references.pmid: 9007070
references.citation: Nat Immunol. 2010 Nov;11(11):997-1004
references.pmid: 20890285
references.citation: J Exp Med. 2002 Feb 18;195(4):517-28
references.pmid: 11854364
references.citation: J Immunol. 1992 Jul 15;149(2):581-9
references.pmid: 1378069
references.citation: Annu Rev Immunol. 1999;17:189-220
references.pmid: 10358757
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3516-21
references.pmid: 14993594
references.citation: mBio. 2011 Aug 09;2(4):
references.pmid: 21828218
references.citation: Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14759-63
references.pmid: 9405686
references.citation: Immunity. 2010 Dec 14;33(6):955-66
references.pmid: 21130004
references.citation: Annu Rev Immunol. 2009;27:229-65
references.pmid: 19302040
references.citation: J Virol. 2005 Jan;79(1):661-7
references.pmid: 15596864
references.citation: J Exp Med. 2001 Jul 2;194(1):29-44
references.pmid: 11435470
references.citation: Science. 2001 May 4;292(5518):934-7
references.pmid: 11340207
references.citation: J Interferon Cytokine Res. 2011 Feb;31(2):211-8
references.pmid: 21226618
references.citation: Immunity. 2004 Jun;20(6):747-56
references.pmid: 15189739
references.citation: Clin Infect Dis. 2006 Nov 1;43(9):1143-51
references.pmid: 17029132
references.citation: J Virol. 1997 Jan;71(1):267-75
references.pmid: 8985346
references.citation: J Immunol. 2000 Nov 1;165(9):4787-91
references.pmid: 11046000
references.citation: Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):634-9
references.pmid: 9012836
references.citation: J Virol. 2010 Jan;84(1):585-98
references.pmid: 19846511
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13483-8
references.pmid: 14597723
references.citation: Rev Med Virol. 2010 Jan;20(1):4-22
references.pmid: 20041442
references.citation: J Virol. 2006 Jul;80(14):6873-82
references.pmid: 16809293
references.citation: Immunol Rev. 2009 Jan;227(1):75-86
references.pmid: 19120477
references.citation: J Virol. 2011 Jun;85(12):6065-76
references.pmid: 21471238
references.citation: Immunol Cell Biol. 2007 Jan;85(1):46-54
references.pmid: 17146464
references.citation: Cell Host Microbe. 2012 Mar 15;11(3):290-7
references.pmid: 22423968
references.citation: J Exp Med. 2003 Apr 7;197(7):885-98
references.pmid: 12682109
references.citation: Nat Genet. 2001 May;28(1):42-5
references.pmid: 11326273
references.citation: J Virol. 1988 Mar;62(3):987-97
references.pmid: 2828694
references.citation: J Virol. 1991 Jun;65(6):3330-4
references.pmid: 1851880
references.citation: Cell Microbiol. 2004 Aug;6(8):707-17
references.pmid: 15236638
references.citation: Infect Immun. 1982 Jul;37(1):143-50
references.pmid: 6179875
references.citation: Proc Natl Acad Sci U S A. 2010 May 25;107(21):9759-64
references.pmid: 20457904
references.citation: Immunity. 2001 Oct;15(4):617-26
references.pmid: 11672543
references.citation: Cell Host Microbe. 2008 Feb 14;3(2):67-76
references.pmid: 18312841
references.citation: J Intern Med. 2010 May;267(5):483-501
references.pmid: 20433576
references.citation: J Exp Med. 2005 May 16;201(10):1543-53
references.pmid: 15883169
references.citation: Science. 2002 May 17;296(5571):1323-6
references.pmid: 11950999
references.citation: J Exp Med. 2010 Jun 7;207(6):1333-43
references.pmid: 20513749
references.citation: J Exp Med. 1995 Oct 1;182(4):1045-56
references.pmid: 7561678
references.citation: J Immunol. 2002 Oct 15;169(8):4279-87
references.pmid: 12370359
references.citation: Trends Microbiol. 2005 Apr;13(4):164-74
references.pmid: 15817386
references.citation: J Immunol. 2005 Nov 15;175(10):6723-32
references.pmid: 16272328